Pegloticase and Allopurinol Interaction

Drug interaction information between Pegloticase and Allopurinol.

Pegloticase and Allopurinol have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Pegloticase and Allopurinol. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Pegloticase

Recombinant Uricase

Drug B

Allopurinol

Xanthine Oxidase Inhibitor

How They Interact

Allopurinol can hide changes in your blood levels that warn doctors of a possible severe allergic reaction to pegloticase.

FDA Label Information

( 7.2 ) Pegloticase: Discontinue and refrain from initiating treatment with allopurinol tablets. Pegloticase Clinical Impact Concomitant use of allopurinol tablets and pegloticase may potentially blunt the rise of serum uric acid levels and increase the risk of pegloticase related anaphylaxis in patients whose uric acid level increase to above 6 mg/dL. Intervention Discontinue and do not institute allopurinol tablets therapy during treatment with pegloticase.

Pegloticase Also Interacts With

View all Pegloticase interactions →

Frequently Asked Questions

What SPL severity band is on file for Pegloticase + Allopurinol?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Allopurinol has 10 labeled pairs on file vs Pegloticase's 2. In the major band specifically: Pegloticase has 1; Allopurinol has 1.

What mechanism field is on file for Pegloticase and Allopurinol?

Allopurinol can hide changes in your blood levels that warn doctors of a possible severe allergic reaction to pegloticase.

Allopurinol's labeled portfolio outnumbers Pegloticase

SPL source-record counts only. This page's band is major · classes on file: Pegloticase (Recombinant Uricase); Allopurinol (Xanthine Oxidase Inhibitor).

Pegloticase

1 major · 0 moderate · 1 minor · 2 total

Pegloticase has no other major-band peer in this dataset besides Allopurinol.

Allopurinol

1 major · 3 moderate · 6 minor · 10 total

Allopurinol has no other major-band peer in this dataset besides Pegloticase.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.